SRC and rhabdomyosarcoma: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination with the Src-Family Kinase (SFK) Inhibitor Dasatinib in People with Embryonal and Alveolar Rhabdomyosarcoma